NYSE · Asset Management · USD

Abrdn Healthcare Investors (HQH) Stock Analysis

Abrdn Healthcare Investors (HQH) is a Asset Management stock listed on NYSE and quoted in US Dollar.

HQH

$22.56

−$0.09 (−0.40%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare HQH with… →

HQH Key Statistics

As of Sep 4, 2026

Trading

Open: $22.61
Previous Close: $22.65
Day's Range: 22.47–22.65
52-Week Range: 16.36–24.85
Volume: 79.50K
Beta: 0.74

Valuation

P/E Ratio: 5.07
EPS (ttm): 4.45

Financials (FY)

Revenue (FY): $99.81M−46.47%
Net Income (FY): $98.61M−46.68%
Profit margin: 4561.32%
1-Year Return: +48.04%

Dividend and dates

Dividend: $2.47+10.91%
Ex-Dividend Date: August 24, 2026
Avg Volume: 221.85K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

HQH Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

−17.37%+34.12%+26.76%

2016*2017201820192020202120222023202420252026*

Year	Return
2026 (partial year)	+26.76%
2025	+34.12%
2024	+10.23%
2023	+1.22%
2022	−17.27%
2021	+7.99%
2020	+24.82%
2019	+26.80%
2018	−13.08%
2017	+15.97%
2016 (partial year)	−17.37%

As of September 4, 2026.

HQH Revenue and Earnings by Fiscal Year

FY ends September

RevenueNet income

2022202320242025

Fiscal year	Revenue	Net income	Net margin
2025	$99.81M	$98.61M	98.8%
2024	$186.46M	$184.95M	99.2%
2023	$58.12M	$56.33M	96.9%
2022	−$192.26M	−$194.23M	101.0%

Fiscal year	Revenue	Gross profit	Operating income	Net income	Net margin
2025	$99.81M	—	—	$98.61M	98.8%
2024	$186.46M	—	—	$184.95M	99.2%
2023	$58.12M	—	—	$56.33M	96.9%
2022	−$192.26M	—	—	−$194.23M	101.0%

Annual figures as reported, in the company's reporting currency. As of September 30, 2025.

HQH Dividend History

’16’17’18’19’20’21’22’23’24’25’26*

$2.19−3.9% vs 2024

Dividends per share, 2025 · 4 payments

Year	Dividends per share	Payments	Change
2026*	$1.90	3	—
2025	$2.19	4	−3.9%
2024	$2.28	4	+42.5%
2023	$1.60	4	−6.4%

Year	Dividends per share	Payments	Change
2026 (partial year)	$1.90	3	—
2025	$2.19	4	−3.9%
2024	$2.28	4	+42.5%
2023	$1.60	4	−6.4%
2022	$1.71	4	−16.2%
2021	$2.04	4	+7.4%
2020	$1.90	5	+10.5%
2019	$1.72	4	−10.9%
2018	$1.93	4	−2.5%
2017	$1.98	4	+296.0%
2016	$0.50	1	—

Most recent payment: $0.63 per share, ex-dividend August 24, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

HQH Valuation vs Asset Management Median

Median of 561 stocks

Metric	HQH	Asset Management median	vs median
P/E	5.07	10.34	51% below
Profit margin	4561.32%	24.09%	4537.2 pts above

Medians across 561 Asset Management stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Abrdn Healthcare Investors trades under the ticker HQH. It is classified in the Asset Management industry, within the Financial Services sector.

Over the past 52 weeks the price has ranged from $16.36 to $24.85. HQH last closed at $22.56 on September 4, 2026. That is −$0.09 (−0.40%) against the previous close. The latest close sits 37.9% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $99.81M. That is −46.47% against the prior fiscal year, when revenue was $186.46M. Net income for the same year was $98.61M. That is −46.68% against the prior fiscal year. Profit margin runs at 4,561.32%. That is 4,537.2 percentage points above the Asset Management median of 24.09%. Trailing earnings per share are 4.45.

Across the 4 fiscal years on file, revenue moves from −$192.26M in 2022 to $99.81M in 2025. Of those 4 years, 3 report positive net income.

Valuation Assessment

HQH trades at a trailing price-to-earnings ratio of 5.07. That is 50.97% below the Asset Management median of 10.34. 561 Asset Management companies report these metrics, and the medians quoted come from that group.

The trailing one-year price return is +48.04%. Measured over 10 years, that is +9.23% a year compounded. The reported beta is 0.74. Annualized volatility over the trailing 10 years is 21.44%.

Growth & Income

Shareholders receive a dividend, yielding 10.91% on the latest price. That is 2.8 percentage points above the Asset Management median yield of 8.11%. At the indicated rate that is $2.47 a share a year. The ex-dividend date on file is August 24, 2026. Dividends are recorded for 11 calendar years; 2026 shows 3 payments totalling $1.90 a share. The year before, 2025, totalled $2.19 a share.

Across the complete calendar years on file, 2025 returned +34.12% and 2022 returned −17.27%. Of the 9 complete calendar years on file, 7 finished higher. 2026 is still running; the price is +26.76% year to date.

Peer Comparison

Abrdn Healthcare Investors (HQH) operates in the Asset Management industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Abrdn Healthcare Investors	HQH	—	5.1
BlackRock, Inc.	BLK	$182.35B	26.9
Blackstone Inc.	BX	$162.74B	30.5
KKR & Co. Inc.	KKR	$99.50B	34.4

The Asset Management industry average P/E ratio is 10.3x. Abrdn Healthcare Investors trades at a P/E of 5.1.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Asset Management Stocks

BLK

BlackRock, Inc.

$182.35B

Blackstone Inc.

$162.74B

KKR

KKR & Co. Inc.

$99.50B

Brookfield Corporation

$89.99B

BAM

Brookfield Asset Management Ltd.

$80.82B

APO

Apollo Global Management, Inc.

$78.94B

View all Asset Management stocks →

Popular Financial Services Stocks

BRK-B

Berkshire Hathaway Inc.

$1.08T

JPM

JPMorgan Chase & Co.

$953.33B

Visa Inc.

$700.27B

Mastercard Incorporated

$507.39B

BAC

Bank of America Corporation

$438.31B

View all Financial Services stocks →

About Abrdn Healthcare Investors

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.